Certain viruses, called oncolytic viruses, have been studied for their ability to selectively infect and destroy cancer cells. These viruses are genetically modified to target cancer-specific receptors and replicate within cancer cells, leading to cell death. Some oncolytic viruses have shown promising results in clinical trials for treating various cancers, but they are still in the experimental stages, and their long-term effectiveness and safety need to be further evaluated.
It's important to note that oncolytic viruses are not a universal cure for cancer. They may be effective in treating some types of cancer but not others. Additionally, viruses can have side effects and may not be suitable for all patients.
Cancer research is ongoing, and scientists are exploring a range of approaches to find effective treatments for different types of cancer. This includes the study of oncolytic viruses, targeted therapies, immunotherapy, and other innovative strategies.